Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.
Pharmacy benefit management giant Express Scripts unveiled several steps it's taking to boost transparency and mitigate high ...
Trump's pick for HHS Secretary faces questions from the left and right over his health stances. But will that stop his ...
Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback